Please login to the form below

Not currently logged in
Email:
Password:

lawsuit

This page shows the latest lawsuit news and features for those working in and with pharma, biotech and healthcare.

FDA starts review of Biogen’s Tecfidera follow-up for MS

FDA starts review of Biogen’s Tecfidera follow-up for MS

Meanwhile, a patent opposition lawsuit is also ongoing in Europe. Biogen is hoping to be able to defend its MS franchise with the launch of Vumerity , even as it tries to

Latest news

More from news
Approximately 9 fully matching, plus 292 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made about

  • Market access improvements in Turkey Market access improvements in Turkey

    Industry successfully filed a lawsuit against the Ministry of Health for the lack of updates.

  • Pharma deals during December 2014 Pharma deals during December 2014

    Acquisitions are frequently complicated by external factors and a day after the Merck acquisition was announced Cubist lost its Cubicin patent infringement lawsuit against Hospira in the US.

  • Healthcare industry apps Healthcare industry apps

    In addition, Amazon has recently opened its own 'App Store' (Apple is currently contesting Amazon's use of the term App Store in a US lawsuit) for its Kindle Fire tablet

  • Country report: The healthcare market in Japan Country report: The healthcare market in Japan

    Takeda also faces lawsuits involving alleged side effects of Actos. Last year, the US Food and Drug Administration reported that longterm Actos users were at a slightly increased risk of developing

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Article: The Colombia Conundrum

    More than 346, 000 lawsuits of this nature were raised between 2006 and 2008, with courts usually deciding in favor of the patients. As the number of lawsuits increased exponentially in

  • Clinical data Transparency

    Amidst extensive criticism the pharmaceutical industry has called for more carrot as an incentive for companies to begin releasing their data; and in the face of two lawsuits even the European

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics